United Kingdom Continuous Glucose Monitoring Market: Growth Opportunities and Competitive Landscape Overview 2025-2033

Key Insights

The United Kingdom Continuous Glucose Monitoring (CGM) market is experiencing robust growth, driven by increasing prevalence of diabetes, technological advancements in CGM devices offering improved accuracy and ease of use, and rising patient preference for non-invasive blood glucose monitoring. The market's Compound Annual Growth Rate (CAGR) of 15.90% from 2019 to 2024 suggests a significant expansion, and this upward trajectory is expected to continue through 2033. While precise market size data for the UK is absent, leveraging the global CAGR and considering the UK's substantial healthcare sector and high diabetes prevalence, a reasonable estimate for the UK market size in 2025 could be around £300 million. This figure is a conservative projection based on global market trends and the UK's economic standing. Key market segments include sensors and durable medical equipment, with major players such as Abbott Diabetes Care, Dexcom, and Medtronic dominating the market. However, the presence of smaller companies and ongoing innovation suggests future market share dynamism. Growth restraints include high device costs, potential for sensor malfunctions, and the need for increased patient education and awareness concerning the benefits of CGM technology. Future trends include the integration of CGM data with insulin pumps for closed-loop systems, the development of more accurate and less invasive sensors, and increased focus on remote monitoring capabilities enhancing patient care and improving clinical outcomes.

The continued growth of the UK CGM market hinges on several factors. Governmental support for advanced diabetes management programs, alongside increased insurance coverage for CGM devices, will be pivotal. Furthermore, technological advancements targeting improved accuracy, reduced cost, and enhanced user experience will play a key role in driving adoption. The emphasis on proactive diabetes management, facilitated by CGM data, is likely to influence healthcare policies and clinical guidelines. Therefore, the combination of technological innovation, supportive regulatory frameworks, and increased patient awareness is set to propel the growth of the UK Continuous Glucose Monitoring market in the coming years.

United Kingdom Continuous Glucose Monitoring (CGM) Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the United Kingdom Continuous Glucose Monitoring (CGM) market, encompassing market dynamics, growth trends, competitive landscape, and future outlook. The report covers the period 2019-2033, with a focus on the 2025-2033 forecast period. The parent market is the UK medical device market, while the child market is the UK diabetes management market. This report is invaluable for industry professionals, investors, and stakeholders seeking to understand and capitalize on the growth opportunities within this dynamic sector. Market values are presented in million units.

United Kingdom Continuous Glucose Monitoring Market Market Dynamics & Structure

The UK CGM market is characterized by a moderately concentrated landscape with key players like Abbott Diabetes Care, Dexcom Inc, Medtronic PLC, and Ascensia Diabetes Care holding significant market share. However, the presence of smaller players and emerging technologies fosters competition. Technological innovation, driven by advancements in sensor technology, data analytics, and integration with smart devices, is a key growth driver. The regulatory framework, including NICE guidelines and reimbursement policies, significantly influences market access and adoption rates. Competitive substitutes, such as self-monitoring blood glucose (SMBG) systems, continue to exist, but CGM's advantages in convenience and data-driven insights are gradually shifting market preference. The end-user demographic primarily consists of individuals with type 1 and type 2 diabetes, with a growing focus on pediatric and geriatric populations. M&A activity within the sector has been moderate, with strategic partnerships and collaborations playing a more prominent role in shaping the market landscape.

• Market Concentration: Moderately concentrated, with top 5 players holding xx% market share in 2024.
• Technological Innovation: Miniaturization, improved accuracy, and wireless connectivity are key drivers.
• Regulatory Landscape: NICE guidelines and NHS reimbursement policies influence market access.
• Competitive Substitutes: SMBG remains a competitor, but CGM adoption is increasing.
• End-User Demographics: Primarily adults with type 1 and type 2 diabetes, expanding to pediatric and geriatric segments.
• M&A Activity: Moderate activity, with xx deals recorded between 2019-2024.

United Kingdom Continuous Glucose Monitoring Market Growth Trends & Insights

The UK CGM market has witnessed significant growth over the historical period (2019-2024), driven by increasing diabetes prevalence, rising healthcare expenditure, and enhanced patient awareness. The market size reached xx million units in 2024 and is projected to expand at a CAGR of xx% during the forecast period (2025-2033), reaching xx million units by 2033. This growth is fueled by technological advancements leading to improved accuracy, ease of use, and reduced cost, as well as increasing acceptance by healthcare professionals and rising patient demand for improved diabetes management. Increased integration with mobile applications and telehealth platforms further enhances the value proposition of CGMs. The market penetration rate is expected to increase from xx% in 2024 to xx% by 2033. Consumer behavior is shifting towards greater self-management of diabetes, driving demand for convenient and effective monitoring solutions like CGMs. Technological disruptions, such as the introduction of more accurate and user-friendly devices, continue to propel market growth.

Dominant Regions, Countries, or Segments in United Kingdom Continuous Glucose Monitoring Market

The UK CGM market exhibits relatively even distribution across its regions, with no single area exhibiting significant dominance. However, the greater London and South East regions generally see higher adoption rates due to greater concentration of healthcare facilities and higher disposable income. In terms of product segments, the Sensors component is currently the dominant segment, contributing xx% of the overall market value in 2024. This dominance is expected to continue throughout the forecast period driven by the continuous need for sensor replacements and the high volume of sensor units compared to other components. The Durables segment (receivers, transmitters) is experiencing relatively slower growth, mainly due to lower replacement frequency.

• Key Drivers for Sensors Segment:
  • High replacement frequency of sensors.
  • Technological advancements in sensor accuracy and longevity.
  • Growing prevalence of diabetes.
• Dominance Factors: Higher unit sales volume compared to Durables.
• Growth Potential: Continued growth driven by technological advancements and increased diabetes prevalence.

United Kingdom Continuous Glucose Monitoring Market Product Landscape

The UK CGM market showcases a range of innovative products, including flash glucose monitoring systems and real-time CGMs, offering varying degrees of accuracy, ease of use, and data reporting capabilities. Key features include smaller and less invasive sensors, improved accuracy, and seamless integration with mobile apps and cloud-based data platforms. The products are tailored to meet diverse needs, including those of pediatric and geriatric populations. These systems offer unique selling propositions, emphasizing real-time data availability, alert functionalities for hypo- and hyperglycemia, and data analysis to support personalized diabetes management. Technological advancements focus on improving accuracy, reducing sensor calibration frequency, and extending sensor lifespan.

Key Drivers, Barriers & Challenges in United Kingdom Continuous Glucose Monitoring Market

Key Drivers:

• Rising prevalence of diabetes.
• Increasing healthcare expenditure.
• Technological advancements leading to improved accuracy, ease of use, and reduced cost.
• Growing acceptance by healthcare professionals and patients.
• Government initiatives supporting diabetes management.

Challenges and Restraints:

• High initial cost of CGM systems, representing a significant barrier to wider adoption. This leads to xx% of the potential market remaining untapped in 2024.
• Reimbursement policies and access to NHS funding can restrict market growth.
• Competition from established SMBG systems.
• Concerns regarding sensor accuracy and reliability in certain patient populations.

Emerging Opportunities in United Kingdom Continuous Glucose Monitoring Market

Emerging opportunities lie in expanding market penetration among underserved populations, particularly in the pediatric and geriatric segments. The integration of CGM data with other health metrics (e.g., activity levels, sleep patterns) offers significant potential for personalized diabetes management. The development of closed-loop systems that automate insulin delivery presents an exciting future direction. Furthermore, the increasing adoption of telehealth and remote patient monitoring offers avenues for expansion.

Growth Accelerators in the United Kingdom Continuous Glucose Monitoring Market Industry

Technological breakthroughs, such as the development of more accurate, user-friendly, and cost-effective CGM systems, are crucial growth drivers. Strategic partnerships between CGM manufacturers, healthcare providers, and technology companies are fostering market expansion. Expansion into untapped market segments, such as those with type 2 diabetes and specific patient populations like children and elderly, is likely to boost market growth. Furthermore, greater investment in research and development and continuous improvement in product features are accelerating market growth.

Key Players Shaping the United Kingdom Continuous Glucose Monitoring Market Market

• Abbott Diabetes Care
• GlySens
• Dexcom Inc
• Eversense
• Medtronic PLC
• Other Company Share Analyse
• Ascensia Diabetes Care

Notable Milestones in United Kingdom Continuous Glucose Monitoring Market Sector

• October 2022: Abbott's FreeStyle Libre 2 demonstrated significant HbA1c reductions and improved quality of life in a New England Journal of Medicine study.
• April 2022: Dexcom launched the G7 CGM system in the UK, featuring faster sensor warm-up and no finger-stick requirements.

In-Depth United Kingdom Continuous Glucose Monitoring Market Market Outlook

The UK CGM market holds significant potential for future growth, driven by continued technological advancements, expanding diabetes prevalence, and increasing patient awareness. Strategic partnerships and collaborations among stakeholders will further accelerate market penetration. The focus on improving affordability and accessibility of CGM technology, combined with increased integration into broader healthcare ecosystems, promises a robust and dynamic market over the forecast period. Continued innovation and regulatory support will be instrumental in unlocking the full market potential.

United Kingdom Continuous Glucose Monitoring Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables

United Kingdom Continuous Glucose Monitoring Market Segmentation By Geography

• 1. United Kingdom